339 related articles for article (PubMed ID: 19837111)
1. Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications.
Saito H
Pharmacol Ther; 2010 Jan; 125(1):79-91. PubMed ID: 19837111
[TBL] [Abstract][Full Text] [Related]
2. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.
Nigam SK; Bush KT; Bhatnagar V
Nat Clin Pract Nephrol; 2007 Aug; 3(8):443-8. PubMed ID: 17653123
[TBL] [Abstract][Full Text] [Related]
3. Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow.
Di Giusto G; Anzai N; Endou H; Torres AM
Pharmacology; 2008; 81(2):127-36. PubMed ID: 17971680
[TBL] [Abstract][Full Text] [Related]
4. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.
Robertson EE; Rankin GO
Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085
[TBL] [Abstract][Full Text] [Related]
5. Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels.
Buist SC; Klaassen CD
Drug Metab Dispos; 2004 Jun; 32(6):620-5. PubMed ID: 15155553
[TBL] [Abstract][Full Text] [Related]
6. JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2013 Sep; 271(2):285-95. PubMed ID: 23707770
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of rat renal cortical organic anion transporter (OAT1 and OAT3) expression in response to ischemia/reperfusion injury.
Zhang R; Yang X; Li J; Wu J; Peng WX; Dong XQ; Zhou SF; Yu XQ
Am J Nephrol; 2008; 28(5):772-83. PubMed ID: 18441523
[TBL] [Abstract][Full Text] [Related]
8. Roles of organic anion transporters in the progression of chronic renal failure.
Enomoto A; Niwa T
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S27-31. PubMed ID: 17976081
[TBL] [Abstract][Full Text] [Related]
9. Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome.
Schneider R; Meusel M; Renker S; Bauer C; Holzinger H; Roeder M; Wanner C; Gekle M; Sauvant C
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1614-21. PubMed ID: 19794109
[TBL] [Abstract][Full Text] [Related]
10. Structure, function, and regulation of renal organic anion transporters.
You G
Med Res Rev; 2002 Nov; 22(6):602-16. PubMed ID: 12369090
[TBL] [Abstract][Full Text] [Related]
11. Organic anion transporter (Slc22a) family members as mediators of toxicity.
Sweet DH
Toxicol Appl Pharmacol; 2005 May; 204(3):198-215. PubMed ID: 15845414
[TBL] [Abstract][Full Text] [Related]
12. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters.
Shin HJ; Lee CH; Park SJ; Shin JG; Song IS
Arch Pharm Res; 2010 May; 33(5):709-16. PubMed ID: 20512469
[TBL] [Abstract][Full Text] [Related]
14. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.
Burckhardt G; Burckhardt BC
Handb Exp Pharmacol; 2011; (201):29-104. PubMed ID: 21103968
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tissue-specific expression of renal organic anion transporters by hepatocyte nuclear factor 1 α/β and DNA methylation.
Jin L; Kikuchi R; Saji T; Kusuhara H; Sugiyama Y
J Pharmacol Exp Ther; 2012 Mar; 340(3):648-55. PubMed ID: 22160269
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and regulation of drug transporters in the intestine and kidney.
Terada T; Inui K
Biochem Pharmacol; 2007 Feb; 73(3):440-9. PubMed ID: 17137557
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of renal anionic drug transporters.
Masereeuw R; Russel FG
Pharmacol Ther; 2010 May; 126(2):200-16. PubMed ID: 20227439
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta.
Saji T; Kikuchi R; Kusuhara H; Kim I; Gonzalez FJ; Sugiyama Y
J Pharmacol Exp Ther; 2008 Feb; 324(2):784-90. PubMed ID: 18029548
[TBL] [Abstract][Full Text] [Related]
20. Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction.
Brandoni A; Villar SR; Picena JC; Anzai N; Endou H; Torres AM
Hepatology; 2006 May; 43(5):1092-100. PubMed ID: 16628676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
